Latest News
Tenax Therapeutics, Inc.
- Tenax Therapeutics, Inc. Estimates – GETTEX:YBO0
- Form 4 Tenax Therapeutics Inc: ADAR1 Capital Management, LLC (10% Owner) For: 19 October By Investing.com
- Adar1 Capital Management, a 10% owner, buys $1.46m of Tenax Therapeutics
- Three parties each report 1.36M shares of Tenax Therapeutics (TENX).
- SPHERA FUNDS MANAGEMENT LTD. Boosts Tenax Therapeutics Inc (TENX) Stake with 669,800-Share Purchase
- Call option shares count toward Sphera’s amended stake disclosure in Tenax Therapeutics (TENX).
- Sphera Funds Management Discloses 7.09% Stake in Tenax Therapeutics as of September 2026
- A 2.4M-share position in Tenax Therapeutics (TENX) is reported with no sole voting power.
- Tenax Therapeutics pauses LEVEL-2 enrollment to implement enrichment after Phase 3 LEVEL learnings
- Tenax Therapeutics, Inc. Provides Update on Tnx-103 Level and Level-2 Clinical Trials
- Tenax Therapeutics To Amend Level-2 Enrollment Criteria
- Tenax (TENX) Flat at $1.93 — Consolidation Continues 2026-10-02 - Insider Selling Alerts
Headlines from the last 30 days, linking to the original publishers. See all market news →